human | Q5 |
P8189 | J9U ID | 987009461664805171 |
P496 | ORCID iD | 0000-0002-9520-1379 |
P1153 | Scopus author ID | 56370695200 |
P214 | VIAF cluster ID | 28161451312864100639 |
P108 | employer | Hebrew University of Jerusalem | Q174158 |
Hadassah Medical Center | Q2331605 | ||
P735 | given name | Mordecai | Q3862863 |
Mordecai | Q3862863 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q44413115 | A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade |
Q37551273 | A polymorphism in the protein kinase C gene PRKCB is associated with α2-adrenoceptor-mediated vasoconstriction |
Q44680942 | Alpha2-adrenergic receptor-induced vascular constriction in blacks and whites |
Q46466416 | Alpha2B adrenergic receptor 301-303 deletion polymorphism and vascular alpha2 adrenergic receptor response |
Q37375138 | Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade. |
Q36769250 | Blacks have a greater sensitivity to α1-adrenoceptor-mediated venoconstriction compared with whites. |
Q35962388 | CYP2A6 genetic variation and dexmedetomidine disposition |
Q40174813 | CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study. |
Q47915074 | Can SGLT2 Inhibitors Cause Acute Renal Failure? Plausible Role for Altered Glomerular Hemodynamics and Medullary Hypoxia. |
Q35830926 | Catecholamine pathway gene variation is associated with norepinephrine and epinephrine concentrations at rest and after exercise. |
Q34199742 | Co-occurrence of hepatocellular carcinoma and lymphoma in patients with hepatitis C virus cirrhosis. |
Q43809494 | Compound cardiac toxicity of oral erythromycin and verapamil |
Q33848602 | Coronary vasospasm associated with uncontrolled carcinoid tumour |
Q78245072 | Corticosteroid-induced glaucoma attributable to an adrenocorticotropin-secreting malignant carcinoid tumor of the thymus |
Q33955008 | Desensitization of vascular response in vivo: contribution of genetic variation in the [alpha]2B-adrenergic receptor subtype. |
Q46990629 | Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier |
Q46536462 | Effect of the alpha2C-adrenoreceptor deletion322-325 variant on sympathetic activity and cardiovascular measures in healthy subjects |
Q42720508 | Effects of CYP4F2 polymorphism on response to warfarin during induction phase: a prospective, open-label, observational cohort study |
Q43141103 | Effects of folic acid supplementation on the pharmacokinetics and anticoagulant effect of warfarin: an open-label, prospective study of long-term administration in adults. |
Q38970144 | Effects of sex and the common ADRB1 389 genetic polymorphism on the hemodynamic response to dobutamine |
Q33625202 | Effects of variation in the human alpha2A- and alpha2C-adrenoceptor genes on cognitive tasks and pain perception. |
Q33410725 | Estimation of the warfarin dose with clinical and pharmacogenetic data |
Q46741321 | Ethnic and genetic determinants of cardiovascular response to the selective alpha 2-adrenoceptor agonist dexmedetomidine |
Q53142338 | Factor VII R353Q genetic polymorphism is associated with altered warfarin sensitivity among CYP2C9 *1/*1 carriers |
Q42607183 | Factors associated with bleeding in elderly hospitalized patients treated with enoxaparin sodium : a prospective, open-label, observational study. |
Q74709236 | Factors associated with mortality among elderly patients with hypothermia |
Q74294023 | Fulminant Cushing's syndrome due to an ACTH-producing thymic carcinoid |
Q33646237 | GRK5 Gln41Leu polymorphism is not associated with sensitivity to beta(1)-adrenergic blockade in humans. |
Q37210441 | Genetic variants in the alpha2C-adrenoceptor and G-protein contribute to ethnic differences in cardiovascular stress responses. |
Q35658737 | Genetic variation in alpha2-adrenoreceptors and heart rate recovery after exercise. |
Q37351724 | Genetic variation in the alpha1B-adrenergic receptor and vascular response. |
Q34731144 | Genetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humans |
Q35642517 | Genetic variation in the α1A-adrenergic receptor and phenylephrine-mediated venoconstriction. |
Q34827577 | Genetic variations in the α(2A)-adrenoreceptor are associated with blood pressure response to the agonist dexmedetomidine |
Q43923513 | Glucose-6-phosphate dehydrogenase deficiency is associated with increased initial clinical severity of acute viral hepatitis A. |
Q28385491 | Independent regulation of α1 and α2 adrenergic receptor-mediated vasoconstriction in vivo |
Q28290776 | Interethnic differences in drug response: the contribution of genetic variability in beta adrenergic receptor and cytochrome P4502C9 |
Q44862814 | Intrahepatic arterial administration of low-dose methotrexate in patients with severe hepatic graft-versus-host disease: an open-label, uncontrolled trial |
Q45744200 | Local SIgA response following administration of a novel intranasal inactivated influenza virus vaccine in community residing elderly |
Q73616904 | Local and systemic immune response in community-dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine |
Q28206334 | Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine |
Q38719983 | Major Bleeding and Hemorrhagic Stroke With Direct Oral Anticoagulants in Patients With Renal Failure: Systematic Review and Meta-Analysis of Randomized Trials. |
Q43856655 | Major bleeding caused by warfarin in a genetically susceptible patient |
Q51719612 | Massive subcutaneous emphysema in a long-term ventilated patient |
Q43513507 | Mefloquine-induced acute hepatitis |
Q73769062 | Natural course of insulin edema |
Q36056712 | Pharmacogenetics and response to beta-adrenergic receptor antagonists in heart failure |
Q43773276 | Phenytoin metabolic ratio: a putative marker of CYP2C9 activity in vivo |
Q44351201 | Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients |
Q40343196 | Population pharmacokinetic analysis of the active product of dipyrone |
Q34730029 | Post-partum hypocalcemia: idiopatic hypoparathyroidism manifested early in lactation |
Q38384338 | Quantitative Assessment of CYP2C9 Genetic Polymorphisms Effect on the Oral Clearance of S-Warfarin in Healthy Subjects. |
Q51646835 | Response to influenza vaccination in community and in nursing home residing elderly: relation to clinical factors |
Q84269736 | Risk factors for prescribing and transcribing medication errors among elderly patients during acute hospitalization: a cohort, case-control study |
Q34086360 | Safety of low dose methotrexate in elderly patients with rheumatoid arthritis |
Q44340794 | Tariquidar, a selective P-glycoprotein inhibitor, does not potentiate loperamide's opioid brain effects in humans despite full inhibition of lymphocyte P-glycoprotein |
Q33445972 | Teaching empathy through poetry: a clinically based model |
Q87891839 | The Risk for Lung Cancer Incidence with Calcium Channel Blockers: A Systematic Review and Meta-Analysis of Observational Studies |
Q85325962 | The common Arg389gly ADRB1 polymorphism affects heart rate response to the ultra-short-acting β(1) adrenergic receptor antagonist esmolol in healthy individuals |
Q33462930 | The effect of medical students' gender, ethnicity and attitude towards poetry-reading on the evaluation of a required, clinically-integrated poetry-based educational intervention |
Q96811347 | The effect of multidrug exposure on neurological manifestations in carbamazepine intoxication: a nested case-control study |
Q74586910 | The evaluation of pleural effusions in patients with heart failure |
Q33504648 | Ticlopidine-induced thrombotic thrombocytopenic purpura. |
Q78723116 | Use of complementary alternative medicine in patients admitted to internal medicine wards |
Q46495946 | Variation in the alpha2B-adrenergic receptor gene (ADRA2B) and its relationship to vascular response in vivo. |
Q37209353 | Variation in the α(2A) adrenoceptor gene and the effect of dexmedetomidine on plasma insulin and glucose. |
Q46972798 | Variations in the alpha2A-adrenergic receptor gene and their functional effects. |
Q80496694 | Warfarin metabolism and anticoagulant effect: a prospective, observational study of the impact of CYP2C9 genetic polymorphism in the presence of drug-disease and drug-drug interactions |
Q28395337 | Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups |
Search more.